{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T21:18:33Z","timestamp":1791494313327,"version":"4.3.4"},"reference-count":52,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2025,8,12]],"date-time":"2025-08-12T00:00:00Z","timestamp":1754956800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/100020595","name":"National Science and Technology Council","doi-asserted-by":"publisher","award":["113-2314-B-002 \u2212152-MY2"],"award-info":[{"award-number":["113-2314-B-002 \u2212152-MY2"]}],"id":[{"id":"10.13039\/100020595","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005762","name":"National Taiwan University Hospital","doi-asserted-by":"publisher","award":["113-M0023"],"award-info":[{"award-number":["113-M0023"]}],"id":[{"id":"10.13039\/501100005762","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005762","name":"National Taiwan University Hospital","doi-asserted-by":"publisher","award":["114-M0030)"],"award-info":[{"award-number":["114-M0030)"]}],"id":[{"id":"10.13039\/501100005762","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000968","name":"American Heart Association","doi-asserted-by":"publisher","award":["#852429"],"award-info":[{"award-number":["#852429"]}],"id":[{"id":"10.13039\/100000968","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["K23HL159279"],"award-info":[{"award-number":["K23HL159279"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["T32HL007609"],"award-info":[{"award-number":["T32HL007609"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01DK115392"],"award-info":[{"award-number":["R01DK115392"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01HL153004"],"award-info":[{"award-number":["R01HL153004"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01HL155834"],"award-info":[{"award-number":["R01HL155834"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,8,29]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The saline suppression test (SST) and the captopril challenge test (CCT) have traditionally been used to confirm or exclude primary aldosteronism (PA). New guidelines recommend using these tests to predict the likelihood of unilateral PA. This study evaluated the diagnostic accuracy, consistency, and clinical implications of these tests.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We conducted a retrospective study of 531 patients with high-probability features of PA who underwent both SST and CCT to evaluate their accuracy and ability to predict unilateral PA. Adrenal lateralization and surgical treatment decisions were guided by individualized clinical judgment rather than strictly relying on SST\/CCT results.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The rate of PA diagnosis ranged from 47.8% to 97.2% based on SST and CCT criteria. Discordance rates between SST and CCT ranged from 10.9% to 51.6%. In analyses restricted to only patients with clinically overt PA, where suppression testing is not considered necessary, the positivity rates of the SST and CCT were still suboptimal and test discordance persisted. Among patients with lateralizing PA, 6.6% to 27.9% had either a negative SST or CCT interpretation, and among those who achieved Primary Aldosteronism Surgical Outcome-defined biochemical cure after unilateral adrenalectomy, 4.1% to 39.8% had either a negative SST or CCT, and up to 5.1% had false-negative results on both tests.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Well-established aldosterone suppression tests for PA demonstrated substantial inconsistency, false-negative interpretations, and the inability to reliably predict lateralization outcomes in PA. Aldosterone suppression testing, using SST and CCT, lack accuracy for the diagnosis and subtyping of PA in high-risk patients.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/ejendo\/lvaf170","type":"journal-article","created":{"date-parts":[[2025,8,12]],"date-time":"2025-08-12T11:33:39Z","timestamp":1754998419000},"page":"348-358","source":"Crossref","is-referenced-by-count":23,"title":["Discordance and shortcomings of aldosterone suppression tests in primary aldosteronism"],"prefix":"10.1093","volume":"193","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2859-5117","authenticated-orcid":false,"given":"Cheng-Hsuan","family":"Tsai","sequence":"first","affiliation":[{"name":"Center for Adrenal Disorders, Division of Endocrinology, Diabetes, and Hypertension, Brigham and Women's Hospital, Harvard Medical School , Boston, MA 02115 ,","place":["United States"]},{"name":"Division of Cardiology, Department of Internal Medicine, National Taiwan University Hospital and National Taiwan University College of Medicine , Taipei 100 ,","place":["Taiwan"]},{"name":"Primary Aldosteronism Center at National Taiwan University Hospital , Taipei 100 ,","place":["Taiwan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefanie Parisien-La","family":"Salle","sequence":"additional","affiliation":[{"name":"Center for Adrenal Disorders, Division of Endocrinology, Diabetes, and Hypertension, Brigham and Women's Hospital, Harvard Medical School , Boston, MA 02115 ,","place":["United States"]},{"name":"Division of Endocrinology, Department of Medicine, Research Center, Centre Hospitalier de L\u2019Universit\u00e9 de Montr\u00e9al (CHUM) , Montreal 900 ,","place":["Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jenifer M","family":"Brown","sequence":"additional","affiliation":[{"name":"Center for Adrenal Disorders, Division of Endocrinology, Diabetes, and Hypertension, Brigham and Women's Hospital, Harvard Medical School , Boston, MA 02115 ,","place":["United States"]},{"name":"Division of Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School , Boston, MA 02115 ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Newman","sequence":"additional","affiliation":[{"name":"Center for Adrenal Disorders, Division of Endocrinology, Diabetes, and Hypertension, Brigham and Women's Hospital, Harvard Medical School , Boston, MA 02115 ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0121-4866","authenticated-orcid":false,"given":"Chin-Chen","family":"Chang","sequence":"additional","affiliation":[{"name":"Primary Aldosteronism Center at National Taiwan University Hospital , Taipei 100 ,","place":["Taiwan"]},{"name":"Department of Medical Imaging, National Taiwan University Hospital and National Taiwan University College of Medicine , Taipei 100 ,","place":["Taiwan"]},{"name":"Department and Graduate Institute of Forensic Medicine, National Taiwan University College of Medicine , Taipei 100 ,","place":["Taiwan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vin-Cent","family":"Wu","sequence":"additional","affiliation":[{"name":"Primary Aldosteronism Center at National Taiwan University Hospital , Taipei 100 ,","place":["Taiwan"]},{"name":"Division of Nephrology, Department of Internal Medicine, National Taiwan University Hospital and National Taiwan University College of Medicine , Taipei 100 ,","place":["Taiwan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8153-1441","authenticated-orcid":false,"given":"Yen-Hung","family":"Lin","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Department of Internal Medicine, National Taiwan University Hospital and National Taiwan University College of Medicine , Taipei 100 ,","place":["Taiwan"]},{"name":"Primary Aldosteronism Center at National Taiwan University Hospital , Taipei 100 ,","place":["Taiwan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0314-9252","authenticated-orcid":false,"given":"Anand","family":"Vaidya","sequence":"additional","affiliation":[{"name":"Center for Adrenal Disorders, Division of Endocrinology, Diabetes, and Hypertension, Brigham and Women's Hospital, Harvard Medical School , Boston, MA 02115 ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,8,12]]},"reference":[{"issue":"11","key":"2026081120020905900_lvaf170-B1","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1038\/s41574-022-00730-2","article-title":"Primary aldosteronism\u2014a multidimensional syndrome","volume":"18","author":"Turcu","year":"2022","journal-title":"Nat Rev Endocrinol"},{"issue":"6","key":"2026081120020905900_lvaf170-B2","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1161\/HYPERTENSIONAHA.125.24648","article-title":"Nationwide, pragmatic, direct-to-patient primary aldosteronism testing program","volume":"82","author":"Brown","year":"2025","journal-title":"Hypertension"},{"issue":"12","key":"2026081120020905900_lvaf170-B3","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1016\/S2213-8587(21)00210-2","article-title":"Diagnosis and treatment of primary aldosteronism","volume":"9","author":"Reincke","year":"2021","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"2","key":"2026081120020905900_lvaf170-B4","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1001\/jamainternmed.2023.7389","article-title":"Evaluation of a best-practice advisory for primary aldosteronism screening","volume":"184","author":"Charoensri","year":"2024","journal-title":"JAMA Intern Med"},{"issue":"2","key":"2026081120020905900_lvaf170-B5","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1161\/HYPERTENSIONAHA.124.24153","article-title":"Characterizing the origins of primary aldosteronism","volume":"82","author":"Brown","year":"2025","journal-title":"Hypertension"},{"issue":"16","key":"2026081120020905900_lvaf170-B6","doi-asserted-by":"publisher","first-page":"1913","DOI":"10.1016\/j.jacc.2020.02.052","article-title":"Primary aldosteronism in patients in China with recently detected hypertension","volume":"75","author":"Xu","year":"2020","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"2026081120020905900_lvaf170-B7","doi-asserted-by":"publisher","first-page":"e14","DOI":"10.1056\/NEJMimc2401927","article-title":"Targeting a hormonal cause of hypertension","volume":"392","author":"Vaidya","year":"2025","journal-title":"N Engl J Med"},{"issue":"1","key":"2026081120020905900_lvaf170-B8","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1530\/EJE-21-1157","article-title":"Autonomous cortisol secretion is associated with worse arterial stiffness and vascular fibrosis in primary aldosteronism\u2014a cross-sectional study with follow-up data","volume":"187","author":"Tsai","year":"2022","journal-title":"Eur J Endocrinol"},{"issue":"9","key":"2026081120020905900_lvaf170-B9","doi-asserted-by":"publisher","first-page":"1899","DOI":"10.1161\/HYPERTENSIONAHA.122.17964","article-title":"Aldosterone as a mediator of cardiovascular damage","volume":"79","author":"Buffolo","year":"2022","journal-title":"Hypertension"},{"issue":"1","key":"2026081120020905900_lvaf170-B10","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/s12020-022-03168-8","article-title":"Secondary diabetes mellitus due to primary aldosteronism","volume":"79","author":"Moustaki","year":"2023","journal-title":"Endocrine"},{"issue":"1","key":"2026081120020905900_lvaf170-B11","doi-asserted-by":"publisher","first-page":"e230350","DOI":"10.1530\/JOE-23-0350","article-title":"Aldosterone, mitochondria and regulation of cardiovascular metabolic disease","volume":"263","author":"Tsai","year":"2024","journal-title":"J Endocrinol"},{"issue":"4","key":"2026081120020905900_lvaf170-B12","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1093\/ejendo\/lvae119","article-title":"NT-proBNP levels in patients with primary hyperaldosteronism and autonomous cortisol cosecretion","volume":"191","author":"Hirsch","year":"2024","journal-title":"Eur J Endocrinol"},{"issue":"2","key":"2026081120020905900_lvaf170-B13","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1093\/ejendo\/lvaf007","article-title":"Mild autonomous cortisol secretion in patients with aldosterone-producing adenoma and risk for cardiac remodeling and diastolic dysfunction","volume":"192","author":"Tsai","year":"2025","journal-title":"Eur J Endocrinol"},{"issue":"1","key":"2026081120020905900_lvaf170-B14","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/S2213-8587(17)30319-4","article-title":"Cardiovascular events and target organ damage in primary aldosteronism compared with essential hypertension: a systematic review and meta-analysis","volume":"6","author":"Monticone","year":"2018","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"5","key":"2026081120020905900_lvaf170-B15","doi-asserted-by":"publisher","first-page":"1889","DOI":"10.1210\/jc.2015-4061","article-title":"The management of primary aldosteronism: case detection, diagnosis, and treatment: an endocrine society clinical practice guideline","volume":"101","author":"Funder","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"2026081120020905900_lvaf170-B16","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1507\/endocrj.EJ21-0508","article-title":"Japan endocrine society clinical practice guideline for the diagnosis and management of primary aldosteronism 2021","volume":"69","author":"Naruse","year":"2022","journal-title":"Endocr J"},{"issue":"12","key":"2026081120020905900_lvaf170-B17","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1016\/j.jfma.2017.06.004","article-title":"Case detection and diagnosis of primary aldosteronism\u2014the consensus of Taiwan society of aldosteronism","volume":"116","author":"Wu","year":"2017","journal-title":"J Formos Med Assoc"},{"issue":"9","key":"2026081120020905900_lvaf170-B18","doi-asserted-by":"publisher","first-page":"2453","DOI":"10.1210\/clinem\/dgaf284","article-title":"Primary aldosteronism: an endocrine society clinical practice guideline","volume":"110","author":"Adler","year":"2025","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"2026081120020905900_lvaf170-B19","doi-asserted-by":"publisher","first-page":"e230445","DOI":"10.1530\/EC-23-0445","article-title":"Captopril challenge test: an underutilized test in the diagnosis of primary aldosteronism","volume":"13","author":"Jahan","year":"2024","journal-title":"Endocr Connect"},{"issue":"3","key":"2026081120020905900_lvaf170-B20","doi-asserted-by":"publisher","first-page":"1470320319870891","DOI":"10.1177\/1470320319870891","article-title":"The characteristics of captopril challenge test-positive patients using various criteria","volume":"20","author":"Kidoguchi","year":"2019","journal-title":"J Renin Angiotensin Aldosterone Syst"},{"issue":"2","key":"2026081120020905900_lvaf170-B21","doi-asserted-by":"publisher","first-page":"e866","DOI":"10.1210\/clinem\/dgaa812","article-title":"Significance of discordant results between confirmatory tests in diagnosis of primary aldosteronism","volume":"106","author":"Fukumoto","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"key":"2026081120020905900_lvaf170-B22","doi-asserted-by":"publisher","first-page":"1343704","DOI":"10.3389\/fendo.2024.1343704","article-title":"Comparison of saline infusion test and captopril challenge test in the diagnosis of Chinese with primary aldosteronism in different age groups","volume":"15","author":"Sun","year":"2024","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"3","key":"2026081120020905900_lvaf170-B23","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1007\/s12020-024-03885-2","article-title":"Comparison of four confirmatory tests for the diagnosis of primary aldosteronism: Bayesian analysis in the absence of a gold standard","volume":"85","author":"Shen","year":"2024","journal-title":"Endocrine"},{"key":"2026081120020905900_lvaf170-B24","doi-asserted-by":"publisher","first-page":"1495959","DOI":"10.3389\/fendo.2024.1495959","article-title":"Impact of confirmatory test results on subtype classification and biochemical outcome following unilateral adrenalectomy in patients with primary aldosteronism","volume":"15","author":"Daneshpour","year":"2024","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"8","key":"2026081120020905900_lvaf170-B25","doi-asserted-by":"publisher","first-page":"1835","DOI":"10.1161\/HYPERTENSIONAHA.122.19377","article-title":"Performance of confirmatory tests for diagnosing primary aldosteronism: a systematic review and meta-analysis","volume":"79","author":"Leung","year":"2022","journal-title":"Hypertension"},{"issue":"4","key":"2026081120020905900_lvaf170-B26","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1161\/HYPERTENSIONAHA.121.18761","article-title":"Primary aldosteronism: where are we now? Where to from here?","volume":"79","author":"Funder","year":"2022","journal-title":"Hypertension"},{"issue":"1","key":"2026081120020905900_lvaf170-B27","doi-asserted-by":"publisher","first-page":"10","DOI":"10.7326\/M20-0065","article-title":"The unrecognized prevalence of primary aldosteronism: a cross-sectional study","volume":"173","author":"Brown","year":"2020","journal-title":"Ann Intern Med"},{"issue":"1","key":"2026081120020905900_lvaf170-B28","doi-asserted-by":"publisher","first-page":"e45","DOI":"10.1210\/clinem\/dgaa703","article-title":"Aldosterone is aberrantly regulated by Various stimuli in a high proportion of patients with primary aldosteronism","volume":"106","author":"St-Jean","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"issue":"9","key":"2026081120020905900_lvaf170-B29","doi-asserted-by":"publisher","first-page":"2220","DOI":"10.1210\/clinem\/dgae145","article-title":"The spectrum of dysregulated aldosterone production: an international human physiology study","volume":"109","author":"Parksook","year":"2024","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"2026081120020905900_lvaf170-B30","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1161\/HYPERTENSIONAHA.125.24711","article-title":"ACE inhibition to distinguish low-renin hypertension from primary aldosteronism","volume":"82","author":"Tsai","year":"2025","journal-title":"Hypertension"},{"issue":"11","key":"2026081120020905900_lvaf170-B31","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1016\/S2213-8587(24)00200-6","article-title":"Aberrant hormone receptors regulate a wide spectrum of endocrine tumors","volume":"12","author":"Lacroix","year":"2024","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"2","key":"2026081120020905900_lvaf170-B32","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1161\/HYPERTENSIONAHA.107.091827","article-title":"Primary aldosteronism prevalence in Italy study I. Comparison of the captopril and the saline infusion test for excluding aldosterone-producing adenoma","volume":"50","author":"Rossi","year":"2007","journal-title":"Hypertension"},{"issue":"1","key":"2026081120020905900_lvaf170-B33","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1186\/s12902-019-0390-3","article-title":"The captopril challenge test for diagnosing primary aldosteronism in a Chinese population","volume":"19","author":"Zhu","year":"2019","journal-title":"BMC Endocr Disord"},{"issue":"1","key":"2026081120020905900_lvaf170-B34","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1038\/s41440-018-0126-1","article-title":"Predictors of confirmatory test results for the diagnosis of primary hyperaldosteronism in hypertensive patients with an aldosterone-to-renin ratio greater than 20. The SHRIMP study","volume":"42","author":"Okamoto","year":"2019","journal-title":"Hypertens Res"},{"issue":"3","key":"2026081120020905900_lvaf170-B35","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1210\/jc.2017-01530","article-title":"Evaluation of the saline infusion test and the captopril challenge test in Chinese patients with primary aldosteronism","volume":"103","author":"Meng","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"2026081120020905900_lvaf170-B36","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1016\/j.eprac.2020.10.016","article-title":"Seated saline suppression test is comparable with captopril challenge test for the diagnosis of primary aldosteronism: a prospective study","volume":"27","author":"Liu","year":"2021","journal-title":"Endocr Pract"},{"issue":"9","key":"2026081120020905900_lvaf170-B37","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1016\/S2213-8587(17)30135-3","article-title":"Outcomes after adrenalectomy for unilateral primary aldosteronism: an international consensus on outcome measures and analysis of remission rates in an international cohort","volume":"5","author":"Williams","year":"2017","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"11","key":"2026081120020905900_lvaf170-B38","doi-asserted-by":"publisher","first-page":"4113","DOI":"10.1210\/jc.2018-01394","article-title":"Comparison of seated with recumbent saline suppression testing for the diagnosis of primary aldosteronism","volume":"103","author":"Stowasser","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"2026081120020905900_lvaf170-B39","doi-asserted-by":"publisher","first-page":"dgz150","DOI":"10.1210\/clinem\/dgz150","article-title":"Diagnosis of primary aldosteronism by seated saline suppression test-variability between immunoassay and HPLC-MS\/MS","volume":"105","author":"Thuzar","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"issue":"9","key":"2026081120020905900_lvaf170-B40","doi-asserted-by":"publisher","first-page":"e2977","DOI":"10.1210\/clinem\/dgae907","article-title":"The captopril challenge test predicts cardiac structure and dysfunction in primary aldosteronism","volume":"110","author":"Chen","year":"2025","journal-title":"J Clin Endocrinol Metab"},{"issue":"14","key":"2026081120020905900_lvaf170-B41","doi-asserted-by":"publisher","first-page":"1811","DOI":"10.1016\/j.jacc.2017.01.052","article-title":"Prevalence and clinical manifestations of primary aldosteronism encountered in primary care practice","volume":"69","author":"Monticone","year":"2017","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"2026081120020905900_lvaf170-B42","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1161\/HYPERTENSIONAHA.117.10197","article-title":"Confirmatory tests for the diagnosis of primary aldosteronism: a prospective diagnostic accuracy study","volume":"71","author":"Song","year":"2018","journal-title":"Hypertension"},{"issue":"10","key":"2026081120020905900_lvaf170-B43","doi-asserted-by":"publisher","first-page":"1631","DOI":"10.2967\/jnumed.109.064873","article-title":"131I-6beta-iodomethyl-19-norcholesterol SPECT\/CT for primary aldosteronism patients with inconclusive adrenal venous sampling and CT results","volume":"50","author":"Yen","year":"2009","journal-title":"J Nucl Med"},{"issue":"5","key":"2026081120020905900_lvaf170-B44","doi-asserted-by":"publisher","first-page":"1606","DOI":"10.1210\/jc.2011-2830","article-title":"The adrenal vein sampling international study (AVIS) for identifying the major subtypes of primary aldosteronism","volume":"97","author":"Rossi","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2026081120020905900_lvaf170-B45","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1161\/HYPERTENSIONAHA.113.02097","article-title":"An expert consensus statement on use of adrenal vein sampling for the subtyping of primary aldosteronism","volume":"63","author":"Rossi","year":"2014","journal-title":"Hypertension"},{"issue":"2","key":"2026081120020905900_lvaf170-B46","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1210\/clinem\/dgac654","article-title":"Exclusion tests in unilateral primary aldosteronism (ExcluPA) study","volume":"108","author":"Zhu","year":"2023","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"2026081120020905900_lvaf170-B47","doi-asserted-by":"publisher","first-page":"948","DOI":"10.7326\/ANNALS-24-03153","article-title":"Confirmatory testing for primary aldosteronism: a study of diagnostic test accuracy","volume":"178","author":"Leung","year":"2025","journal-title":"Ann Intern Med"},{"issue":"4","key":"2026081120020905900_lvaf170-B48","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1161\/HYPERTENSIONAHA.116.07214","article-title":"Suppression of aldosterone secretion after recumbent saline infusion does not exclude lateralized primary aldosteronism","volume":"68","author":"Cornu","year":"2016","journal-title":"Hypertension"},{"issue":"2","key":"2026081120020905900_lvaf170-B49","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1097\/MNH.0000000000000384","article-title":"The regulation of aldosterone secretion by leptin: implications in obesity-related cardiovascular disease","volume":"27","author":"Faulkner","year":"2018","journal-title":"Curr Opin Nephrol Hypertens"},{"issue":"2","key":"2026081120020905900_lvaf170-B50","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1093\/ejendo\/lvae099","article-title":"Saline suppression testing-induced hypocalcemia and implications for clinical interpretations","volume":"191","author":"Parksook","year":"2024","journal-title":"Eur J Endocrinol"},{"issue":"3","key":"2026081120020905900_lvaf170-B51","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1161\/HYPERTENSIONAHA.120.16429","article-title":"Intraindividual variability of aldosterone concentrations in primary aldosteronism: implications for case detection","volume":"77","author":"Yozamp","year":"2021","journal-title":"Hypertension"},{"issue":"7","key":"2026081120020905900_lvaf170-B52","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1111\/jch.12342","article-title":"High-probability features of primary aldosteronism may obviate the need for confirmatory testing without increasing false-positive diagnoses","volume":"16","author":"Kline","year":"2014","journal-title":"J Clin Hypertens (Greenwich)"}],"container-title":["European Journal of Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ejendo\/advance-article-pdf\/doi\/10.1093\/ejendo\/lvaf170\/64029796\/lvaf170.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ejendo\/article-pdf\/193\/3\/348\/64029796\/lvaf170.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ejendo\/article-pdf\/193\/3\/348\/64029796\/lvaf170.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T00:02:16Z","timestamp":1786492936000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ejendo\/article\/193\/3\/348\/8232743"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,12]]},"references-count":52,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,8,29]]}},"URL":"https:\/\/doi.org\/10.1093\/ejendo\/lvaf170","relation":{},"ISSN":["0804-4643","1479-683X"],"issn-type":[{"value":"0804-4643","type":"print"},{"value":"1479-683X","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,9]]},"published":{"date-parts":[[2025,8,12]]}}}